Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Brain Behav Immun. 2015 Mar 11;49:54–58. doi: 10.1016/j.bbi.2015.03.004

Table 1.

Clinical characteristics of patients and controls

Cohort 1 Cohort 2 Cohort 3
Group Narcolepsy
type 1
Healthy
controls
Narcolepsy
<1 year
Narcolepsy
>1 year
Other
hypersomnia
Narcolepsy
<1 month
Narcolepsy
3 mth −3
N 9 9 16 15 9 5 12
0602 positive 9 5 16 15 9 5 12
Age 22.4 [6-62] 34.3 [18-42] 10.2 ± 0.3 11.2 ± 2.0 10.9 ± 2.6 10.4 ± 2.7 10.2 ± 2.6
BMI * 23.1 [18-31] 23.2 [20-27] 22.2 ± 6.2* 24.4 ± 5.3* 20.4 ± 5.7* 19.6 ± 3.1 19.7 ± 2.5
Sex (M/F) 3/6 3/6 7/9 7/8 5/4 4/1 6/6
Months from
onset
10.2 [2-20] - 3.5 ± 2.5 23.8 ± 7.7 31.4 ± 16.8 0.6 ± 0.2 14.5 ± 9.7
CSF Hcrt-1 47.3 ± 33.9 249.9 ± 28.7 25 ± 29 21 ± 26 364 ± 93 33 ± 23 33 ± 26
*

Data from 1 patient is missing in the three marked groups.